+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

In Vitro Lung Model Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 120 Pages
  • January 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 4986995

The In Vitro Lung Model market is projected to grow with a CAGR of nearly 17.3% over the forecast period. The major factor attributing to the growth of the market is the increase in the awareness and focus on developing alternatives for animal testing models. The shift in focus is due to two reasons, firstly, despite large similarities, there are differences between a given animal species and humans, a second issue regarding the use of animals for scientific purposes is animal protection and welfare. According to Animal Welfare Institute, Russell and Burch’s ‘3Rs’ should be followed which states, replacement of animals in research with alternatives; reduction in the number of animals used in experiments, and refinement of the care and treatment of the animals who continue to be used in research, testing and education. Furthermore, the funding and investments for product development and research are boosting the market growth. However, the lack of skilled labor is the major drawback of the growth of the market.

Key Market Trends

2D Cell Models Segment is Expected to Witness Rapid Growth

2D cell culture systems grow cells on flat dishes, typically made of plastic. The cells are put onto coated surfaces where they adhere and spread. The 2D cell cultures are mostly used as they are less expensive, well established, easier cell observation and measurement and lots of literature are available in them. The 2D cell culture models are used in drug discovery and toxicology, 3D model development and basic research.

The other factors driving the segment growth are, increasing awareness and focus on developing alternatives for animal testing models and increasing investments and fundings for product development and research.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, increasing animal welfare programs and regulations, established healthcare infrastructure. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. In this region, the United States has the maximum share due to supportive healthcare policies, high investments for product development, strict regulations and acts regarding the animal welfare and increasing programs and campaigns for their support, and a developed healthcare market.

Competitive Landscape

The In Vitro Lung Model market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Epithelix, Mattek, Emulate, AlveoliX, ATCC, Mimetas, TissUse, Insphero, Cn Bio Innovations. The market players are focusing on the new product development as there is a growing adoption to the in-vitro models of lungs.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Interest on Developing Alternatives for Animal Testing Models
4.2.2 Increase in Research Funding and Product Development
4.3 Market Restraints
4.3.1 Lack of Skilled Labour
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Type
5.1.1 2D Cell Models
5.1.2 3D Cell Models
5.2 By Application
5.2.1 Drug Screening
5.2.2 Toxicology
5.2.3 Others
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Epithelix
6.1.2 Mattek
6.1.3 Emulate
6.1.4 AlveoliX
6.1.5 ATCC
6.1.6 Mimetas
6.1.7 TissUse
6.1.8 Insphero
6.1.9 Cn Bio Innovations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Epithelix
  • Mattek
  • Emulate
  • AlveoliX
  • ATCC
  • Mimetas
  • TissUse
  • Insphero
  • Cn Bio Innovations